For most of us, Monday is the worst day of the week, but for the Nasdaq lately, it doesn’t get any better than Monday.  The chart below shows the Nasdaq’s performance on Mondays since the closing low for the S&P 500 on 3/23.  On that day, the Nasdaq fell a pedestrian 0.3%.  Since then, Mondays have been a blockbuster.  In the 19 weeks between 3/23 and today, the Nasdaq’s average gain on Mondays (or Tuesday if Monday was a holiday) has been +1.4% with only two declines.  Not only that, but on 13 of those Mondays, the Nasdaq has been up over 1%, including eight of the last nine heading into this week.  On a cumulative basis, half of the Nasdaq’s entire gain off of the March 23rd lows was from Mondays alone.  With the Nasdaq down half of a percent so far today, the magnitude of the decline isn’t all that notable but relative to other Mondays recently, it stands out like a sore thumb.  Click here to view Bespoke’s premium membership options for our best research available.

Over the last few days, we’ve been seeing a moderate rotation in the market as red-hot growth stocks sell-off and investors shift into other areas of the market that have been lagging.  To highlight this, the table below highlights 24 companies in the Russell 3,000 with market caps of more than $1 billion that traded at a 52-week high within the last month but are currently down more than 20% from that high. The vast majority of these stocks are names that investors haven’t been able to get enough of in 2020 but now appear to have had their fill.

Topping the list of these reversals is Eastman Kodak (KODK).  On 7/29, the stock surged to a 52-week high of $60.00 after being awarded a questionable government contract to domestically produce components for prescription drugs.  With the SEC and government agency that originally awarded the contract now looking into stock option awards at the company just before it was announced, the stock has pulled back sharply and is now down over 80% from its high less than two weeks ago.

While KODK is more of a unique example, other names on the list are primarily growth or health care stocks that have benefited from the COVID outbreak. However, now that signs suggest the summer wave in the south has crested, investors appear to be taking some profits.  Shares of Vaxart (VXRT) hit a high of $17.49 on July 14th but have since lost nearly half of their value and trade back in the single-digits.  Additionally, Bloom Energy (BE), 1Life Healthcare (ONEM), and Bioxcel Therapeutics (BTAI) have all lost more than a third of their value.

In terms of market cap, most of the names listed are on the small side, but Tesla (TSLA) is a notable exception as it is now just over 20% below its 52-week high on 7/13.  Other relatively large companies on the list include Moderna (MRNA), Citrix Systems (CTXS), Teladoc (TDOC), and Livongo (LVGO).  TDOC and LVGO both hit all-time highs last week but after announcing a mostly stock merger last Wednesday, both have lost nearly a quarter of their value.

While all of the stocks listed below have seen sharp pullbacks in the last several days, a little perspective is in order.  Of the 24 names listed, the average YTD change even after the declines has been a gain of 219.7% (median: +94.6%).  Only two of the stocks shown (New Relic- NEWR and Sonos- SONO) are down YTD, and half of them have at least doubled and in many cases much more.  Click here to view Bespoke’s premium membership options for our best research available.

Welcome to Bespoke Brunch Reads — a linkfest of the favorite things we read over the past week. The links are mostly market related, but there are some other interesting subjects covered as well. We hope you enjoy the food for thought as a supplement to the research we provide you during the week.

While you’re here, join Bespoke Premium with a 30-day free trial!

Policy Research

California Unemployment Insurance Claims During the COVID-19 Pandemic by Thomas J. Hedin, Geoffrey Schnorr and Till von Wachter (California Policy Lab)

Some startling findings on the nature of jobless claims filers in California: half are re-opened claims, driven by new rounds of firings or hours reduction. One-third of California’s workforce has filed for UI benefits since the start of mid-March. [Link]

Do Unemployment Insurance Benefits Improve Match Quality? Evidence from Recent U.S. Recessions by Ammar Farooq, Adriana D. Kugler, and Umberto Muratori (NBER)

New research argues that more generous UI benefits allow workers to find jobs better-suited to their skills, supporting long-term income and productivity with extra benefits for women, non-white, and lower-education workers. [Link]

The Gulf Between Republicans and Democrats on Coronavirus Aid, in 9 Charts by Alicia Parlapiano (NYT)

A helpful rundown of the priorities each party has in their proposed new round of relief from the COVID shock. [Link; soft paywall]

Investing

With Biotech Stocks, Investors Love the Thrill of the Chase by Gregory Zuckerman and Michael Wursthorn (WSJ)

Risk-seeking individual investors have turned to vaccine plays as a way to scratch their itch for big payoffs and high uncertainty. [Link; paywall]

A Blank-Check ETF May Be Coming After the Surge in SPACs by Katherine Greifeld (Bloomberg)

With the popularity of so-called “blank-check” special purpose acquisition companies (which raise capital then use it to buy out a private company), there is of course an ETF set to track the broad space. [Link; soft paywall]

Political Donations

Schwarzman’s Wallet Props Up Wall Street Elite’s Giving to Trump by Shahien Nasiripour and Hema Parmar (Bloomberg)

The CEO of PE shop Blackstone is accounting for three-quarters of every dollar that Wall Street donates to the President’s re-election campaign. Excluding Schwarzman, donations are down almost 70% versus 2016. [Link; soft paywall]

COVID

Some scientists are taking a DIY coronavirus vaccine, and nobody knows if it’s legal or if it works by Antonio Regalado (MIT Technology Review)

In an effort to develop immunity ahead of the commercially viable alternative, some are taking a basically homemade vaccine that sits on at best legally dubious grounds. [Link; soft paywall]

Agriculture

Wheat yield potential in controlled-environment vertical farms by Senthold Asseng et al (PNAS)

A new study of vertical farming, whereby crops are grown indoors in layers, can produce radically higher crop yields than any current farming technique, creating more calories with fewer resoruces. [Link]

Read Bespoke’s most actionable market research by joining Bespoke Premium today!  Get started here.

Have a great weekend!